Polymorphisms in tumour necrosis factor-?, transforming growth factor-?, interleukin-10, interleukin-6, interferon-?, and outcome of hepatitis C virus infection-Reference-Cited by-同舟云学术

Polymorphisms in tumour necrosis factor-?, transforming growth factor-?, interleukin-10, interleukin-6, interferon-?, and outcome of hepatitis C virus infection

Published:2003-08-18 Issue:2 Volume:71 Page:212-218
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J. Med. Virol.

Author:

Barrett S.,Collins M.,Kenny C.,Ryan E.,Keane C.O.,Crowe J.

Publisher

Wiley

Subject

Infectious Diseases,Virology

Reference39 articles.

1. GENOTYPIC VARIATION IN THE TRANSFORMING GROWTH FACTOR-??1 GENE

2. CA repeat allele polymorphism in the first intron of the human interferon-γ gene is associated with lung allograft fibrosis

3. Association of the HLA-DRB1*01 allele with spontaneous viral clearance in an Irish cohort infected with hepatitis C virus via contaminated anti-D immunoglobulin

4. The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infection

5. Pathogenesis, diagnosis and management of hepatitis C

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SNPs variety of transforming-growth factor-beta 1 (codon 10 and codon 25) genes are related to viral hepatitis (B type and C type) disease in some Iraqi individuals;Gene Reports;2024-09

2. Interleukin-6 Gene (-174 G>C) Polymorphisms in Patients with Chronic Hepatitis C Virus; A Case-Control Study;Hepatitis Monthly;2024-03-16

3. Immunopathogenesis of ocular toxoplasmosis and implications for treatment;Expert Review of Ophthalmology;2023-11-29

4. IL-23/IL-17 Axis in Chronic Hepatitis C and Non-Alcoholic Steatohepatitis—New Insight into Immunohepatotoxicity of Different Chronic Liver Diseases;International Journal of Molecular Sciences;2023-08-05

5. IL-10 and IL-28B gene variants as predictors of sustained response to peginterferon and ribavirin therapy in chronic HCV infection;Cytokine;2022-03